$MTG

MGIC INVESTMENT CORP

No enriched coverage for $MTG in the last 7 days.

No SEC Form 4 filings for $MTG in the last 30 days.

Med

MTG Reports Q1 Revenue of $297.08 Million, Exceeding Expectations

MGIC Investment Corp (MTG) reported Q1 revenue of $297.08 million, slightly missing analyst expectations but with the CEO expressing optimism due to strong execution. The company boasts a GF Score™ of 89/100, indicating robust overall performance, particularly in profitability and growth, despite recent insider selling activity totalling $6.2 million. Its P/E ratio suggests potential undervaluation, making it a point of interest for investors.

MGIC Investment (NYSE:MTG) Price Target Raised to $29.00 at Barclays

Barclays has raised its price target for MGIC Investment (NYSE:MTG) to $29.00 from $28.00, maintaining an "equal weight" rating and suggesting an 8.03% upside. The report highlights significant insider selling activity over the past quarter, with executives selling shares totaling over $9 million. Despite this, the company holds an average analyst rating of "Hold" with a consensus price target of $28.25.